Clinical Trial Update: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases [NA]

View source ↗

Summary

This entry describes an ongoing clinical trial at University Hospital, Bordeaux evaluating whether immune mediators and metabolites can stratify systemic lupus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Systemic Lupus Erythematosus | NA | Status: ACTIVE_NOT_RECRUITING